SCLERO.ORG
Search

Adempas (Riociguat) for Pulmonary Hypertension

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer

Adempas (Riociguat) by Bayer Schering

Take the Next Step With Adempas. Adempas is the first and only medicine approved by the Food and Drug Administration (FDA) for treating two types of pulmonary hypertension in adults: Chronic thromboembolic pulmonary hypertension (CTEPH) and Pulmonary arterial hypertension (PAH). Bayer HealthCare Pharmaceuticals.

Riociguat Drug Information. Prescribing information, side effects, and contraindications. Drugs.com

PAH Drug, Riociguat, Found Not to Alter the Effectiveness of Oral Contraceptives. Women with PAH are advised to avoid having children due to the high mortality rate associated with pregnancy in this condition. Since oral contraceptives are the most common drugs used to prevent pregnancy, it is important to understand how they interact with a drug used to treat PAH. Pulmonary Hypertension News, 05/24/2016.

Go to Stem Cell Transplants
 
Recent Donors
See ISN News for recent donors, including memorials for
Christine Kane, Joleen M. Cascaden.
 

SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA

Email [email protected] to request our Welcome email, or to report bad links or to update this page content.

TOLL FREE HOTLINE 800-564-7099
Free to U.S. and Canadian Callers. Ask for our Free Info Packet by mail or email!
Scleroderma, Pulmonary Arterial Hypertension, and related illnesses.
Privacy Policy.

 
The most important thing in the world to know about scleroderma is sclero.org!
Donate Now
Copyright 1998-2017, International Scleroderma Network. AKA Scleroderma from A to Z and SCLERO.ORG. All Rights Reserved.